Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJE0Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,727
Award facts
- Contract value 100% obligated
- $72,727.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $72,727.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent pen auto-injectors on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The pharmaceutical product being delivered supports military healthcare programs by providing Dupixent, a biologic medication used primarily for treating atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma in eligible military and veteran populations.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. As the prime contractor on the DLA Troop Support Medical IDC, the company demonstrates established capability to meet federal healthcare supply requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard. This delivery order represents a routine execution of the broader global pharmaceutical support vehicle that enables flexible medical commodity sourcing for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FJE0Z?
SPE2DR26FJE0Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FJE0Z worth?
The government has obligated $72,727 on SPE2DR26FJE0Z.
Is contract SPE2DR26FJE0Z an order under another contract?
Yes. SPE2DR26FJE0Z is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJE0Z competed?
The extent of competition for SPE2DR26FJE0Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award